TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy
Clinical trial NCT04695327 · COMPLETED
Trial details
- NCT number
- NCT04695327
- Sponsor
- TILT Biotherapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2025-09-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.